SCHEMBL9259548

SCHEMBL9259548

O=CN(c1ccccc1)c1cccnc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNA5 P22460 5/20 0.50
CYP11B2 P19099 2/20 0.42
CYP11B1 P15538 1/20 0.42
KCNN4 O15554 3/20 0.42
HTT P42858 1/20 0.41
GAA P10253 2/20 0.40
TSHR P16473 1/20 0.40
POLB P06746 1/20 0.39
MAPT P10636 1/20 0.39
MAPK1 P28482 1/20 0.39
ALDH1A1 P00352 2/20 0.38
APP P05067 1/20 0.38
HCAR3 P49019 1/20 0.38
HCAR2 Q8TDS4 1/20 0.38
CFTR P13569 1/20 0.38
SLC6A2 P23975 1/20 0.38
SLC6A4 P31645 1/20 0.38
SLC6A3 Q01959 1/20 0.38
GOPC Q9HD26 1/20 0.38
CYP19A1 P11511 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2861455 0.94 KCNA5 (0.46) KCNA5CYP11B2CYP11B1KCNN4HTT
SCHEMBL9276050 0.82 KMT2A (0.43) KCNA5CYP11B2ALDH1A1SLC6A2SLC6A4
SCHEMBL5516786 0.81 ALDH1A1 (0.42) HTTTSHRPOLBMAPTMAPK1
SCHEMBL43388 0.81 ALDH1A1 (0.42) HTTTSHRPOLBMAPTMAPK1
SCHEMBL18560654 0.81 KCNA5 (0.46) KCNA5CYP11B2CYP11B1KCNN4HTT
SCHEMBL28847835 0.78 KCNA5 (0.46) KCNA5CYP11B2CYP11B1KCNN4HTT
SCHEMBL8504493 0.74 KCNA5 (0.43) KCNA5KCNN4HTTGAAMAPT
SCHEMBL10985893 0.74 KCNA5 (0.43) KCNA5CYP11B2CYP11B1KCNN4HTT
SCHEMBL2646034 0.74 KCNA5 (0.43) KCNA5CYP11B2CYP11B1KCNN4HTT
Hydrochloric Acid SCHEMBL27850698 0.73 KCNA5 (0.42) KCNA5CYP11B2CYP11B1KCNN4HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5405843-A Anticancer drug potentiators MITSUI TOATSU CHEMICALS, INCORPORATED (JP) 1995-04-11 US disclosed
EP-0363212-B1 Novel heterocyclic compounds and anticancer-drug reinforcing agents containing them as effective components MITSUI TOATSU CHEMICALS (JP) 1995-01-04 EP disclosed
US-5204348-A Quinoline derivatives MITSUI TOATSU CHEMICALS INC. (JP) 1993-04-20 US disclosed
US-5112817-A Anticancer Drug Potentiators MITSUI TOATSU CHEMICALS, INCORPORATED (JP) 1992-05-12 US disclosed
EP-0363212-A2 Novel heterocyclic compounds and anticancer-drug reinforcing agents containing them as effective components MITSUI TOATSU CHEMICALS, Inc. (JP) 1990-04-11 EP disclosed